Company Information

CIN
Status
Date of Incorporation
31 March 2018
State / ROC
/ ROC Delhi
Last Balance Sheet
31 July 2021
Last Annual Meeting
20 December 2021
Paid Up Capital
7,250,000
Authorised Capital
8,050,000

Directors

Abhishek Mishra
Abhishek Mishra
Director/Designated Partner
almost 3 years ago
Duncan Richard Preston
Duncan Richard Preston
Director/Designated Partner
almost 5 years ago
Robert Einion Holland
Robert Einion Holland
Director/Designated Partner
almost 5 years ago

Past Directors

Mathai Mathews
Mathai Mathews
Director
over 6 years ago
Balakrishan Subha Sri
Balakrishan Subha Sri
Director
over 6 years ago
Gunjan Gupta
Gunjan Gupta
Director
over 7 years ago

Patents

Immunomodulatory Proteins

A method for treatment of a mammalian subject for an autoimmune or inflammatory disease , the method comprising: administering to the mammalian subject an effective amount of a polymeric protein comprising five , six or seven polypeptide monomer units; wherein each polypeptide monomer unit comprises an Fc receptor b...

Mosquito Bed Net Assembly

Mosquito bed net assembly 10a h includes a mosquito bed net (12) impregnated with a first insecticide and a barrier member 16a h located above an upper surface (14) of the bed net (12) and being impregnated with a second insecticide. In use bed net assembly 16a h increases the likelihood of delivering a lethal dosa...

Monomeric Proteins And Uses Thereof

Provided are proteins comprising two chimeric polypeptide chains; wherein each chimeric polypeptide chain comprises an Fc receptor binding portion comprising two immunoglobulin G heavy chain constant regions; and an immunoglobulin tailpiece region. The amino acid sequence and glycosylation of the tailpiece region of...

Chimeric Fc Receptor Binding Proteins And Uses Thereof

The present invention relates to chimeric proteins, to compositions comprising such proteins and to the medical uses of such proteins and compositions. In particular the proteins or compositions of the invention may be used in the prevention or treatment of autoimmune diseases or inflammatory diseases, or for the pr...

Combination Product

The present invention relates to a combination therapeutic product comprising one or more respiratory electron transport chain inhibitors and a cytochrome bd inhibitor, as defined herein, or a pharmaceutically acceptable salt thereof. The present invention also relates to pharmaceutical compositions comprising the c...